Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Insulin vs Humulin R in Diabetes (China, Phase III)
CTR20170414Phase 3Completed
- Sponsor
- Wanbang Biopharmaceuticals
- Start
- May 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of human insulin in diabetes mellitus type 1 (T1D), type 2 diabetes mellitus (T2DM), sponsored by Wanbang Biopharmaceuticals. Started May 2017; status: completed.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20170414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170414.